BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

111 related articles for article (PubMed ID: 8387047)

  • 1. Nitecapone effect on the synthesis and secretion of gastric sulfomucin.
    Slomiany BL; Liau YH; Lopez RA; Slomiany A
    Gen Pharmacol; 1993 Jan; 24(1):69-73. PubMed ID: 8387047
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Effect of ebrotidine on the synthesis and secretion of gastric sulfomucin.
    Slomiany BL; Lopez RA; Liau YH; Slomiany A
    Gen Pharmacol; 1993 May; 24(3):611-7. PubMed ID: 8365641
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Synthesis and secretion of gastric sulfomucin in the presence of ebrotidine, a new antiulcer agent.
    Slomiany BL; Lopez RA; Slomiany A
    Biochem Int; 1992 Dec; 28(4):665-74. PubMed ID: 1482403
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Helicobacter pylori lipopolysaccharide effect on the synthesis and secretion of gastric sulfomucin.
    Liau YH; Lopez RA; Slomiany A; Slomiany BL
    Biochem Biophys Res Commun; 1992 May; 184(3):1411-7. PubMed ID: 1590801
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Glycosulfatase activity of Helicobacter pylori towards gastric sulfomucin: effect of nitecapone.
    Slomiany BL; Murty VL; Piotrowski J; Morita M; Slomiany A
    J Physiol Pharmacol; 1993 Mar; 44(1):7-16. PubMed ID: 8518427
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Inhibition of Helicobacter pylori glycosulfatase activity toward gastric sulfomucin by nitecapone.
    Murty VL; Piotrowski J; Morita M; Slomiany A; Slomiany BL
    Biochem Int; 1992 May; 26(6):1091-9. PubMed ID: 1632804
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Protection against alcohol-induced gastric mucosal injury by nitecapone.
    Slomiany BL; Piotrowski J; Ismail A; Rajiyah G; Tamura S; Bielanski W; Slomiany A
    Gen Pharmacol; 1991; 22(6):1055-62. PubMed ID: 1810804
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Protection by nitecapone against sodium taurocholate-induced damage to cultured gastric cells.
    Tu Y; Ranta S; Nissinen E; Lindén IB
    Dig Dis Sci; 1993 Apr; 38(4):701-7. PubMed ID: 7681749
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Inhibition of gastric mucosal laminin receptor by Helicobacter pylori lipopolysaccharide: effect of nitecapone.
    Slomiany BL; Piotrowski J; Rajiah G; Slomiany A
    Gen Pharmacol; 1991; 22(6):1063-9. PubMed ID: 1839788
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Role of sulfation in the processing of gastric mucins.
    Liau YH; Murty VL; Slomiany A; Bielanski W; Slomiany BL
    J Physiol Pharmacol; 1991 Dec; 42(4):357-66. PubMed ID: 1726711
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Role of gastric mucosal eicosanoid production in the cytoprotection induced by nitecapone.
    Aho PA; Lindén IB
    Scand J Gastroenterol; 1992; 27(2):134-8. PubMed ID: 1561527
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Inhibition of Helicobacter pylori glycosulfatase activity towards human gastric sulfomucin by a gastroprotective agent, sulglycotide.
    Murty VL; Piotrowski J; Czajkowski A; Slomiany A; Slomiany BL
    Gen Pharmacol; 1993 Nov; 24(6):1463-6. PubMed ID: 8112521
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Enhancement of gastric mucus phospholipid secretion by an antiulcer agent, ebrotidine.
    Slomiany BL; Piotrowski E; Piotrowski J; Zirvi KA; Liau YH; Murty VL; Slomiany A
    Gen Pharmacol; 1994 Sep; 25(5):1033-7. PubMed ID: 7835621
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Role of sulfation in post-translational processing of gastric mucins.
    Liau YH; Slomiany A; Slomiany BL
    Int J Biochem; 1992 Jul; 24(7):1023-8. PubMed ID: 1383042
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Effect of bismuth and nitecapone on acetaldehyde production by Helicobacter pylori.
    Salmela KS; Roine RP; Höök-Nikanne J; Kosunen TU; Salaspuro M
    Scand J Gastroenterol; 1994 Jun; 29(6):528-31. PubMed ID: 8079111
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Effects of ecabet sodium, a novel gastroprotective agent, on mucin metabolism in rat gastric mucosa.
    Ichikawa T; Ishihara K; Hayashida H; Hiruma H; Saigenji K; Hotta K
    Dig Dis Sci; 2000 Mar; 45(3):606-13. PubMed ID: 10749340
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Stimulation of mucosal alkaline secretion in rat duodenum by dopamine and dopaminergic compounds.
    Flemström G; Säfsten B; Jedstedt G
    Gastroenterology; 1993 Mar; 104(3):825-33. PubMed ID: 8095035
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Inhibition of human erythrocyte and gastroduodenal catechol-O-methyltransferase activity by nitecapone.
    Schultz E; Tarpila S; Bäckström AC; Gordin A; Nissinen E; Pohto P
    Eur J Clin Pharmacol; 1991; 40(6):577-80. PubMed ID: 1884738
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Effect of Helicobacter pylori lipopolysaccharide on the synthesis of sulfated gastric mucin.
    Slomiany BL; Liau YH; Lopez RA; Piotrowski J; Czajkowski A; Slomiany A
    Biochem Int; 1992 Aug; 27(4):687-97. PubMed ID: 1417902
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Duodenal bicarbonate secretion and mucosal protection. Neurohumoral influence and transport mechanisms.
    Säfsten B
    Acta Physiol Scand Suppl; 1993; 613():1-43. PubMed ID: 7905692
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 6.